LON:INDV - Indivior Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
GBX 124.55 -0.70 (-0.56 %)
(As of 01/17/2019 04:00 PM ET)
Previous CloseGBX 125.25
Today's RangeGBX 122.45 - GBX 128.35
52-Week RangeGBX 246.50 - GBX 436.60
Volume1.63 million shs
Average Volume2.44 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence. The company's product pipeline focuses on treating opioid use disorder, alcohol use disorder, overdose rescue, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy analgesic products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC was incorporated in 2014 and is headquartered in Richmond, Virginia.

Receive INDV News and Ratings via Email

Sign-up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drugs - Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+44-1753-217800

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees900
OptionableNot Optionable

Indivior (LON:INDV) Frequently Asked Questions

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

What price target have analysts set for INDV?

5 Wall Street analysts have issued 12-month target prices for Indivior's shares. Their forecasts range from GBX 130 to GBX 398. On average, they expect Indivior's share price to reach GBX 260.60 in the next year. This suggests a possible upside of 109.2% from the stock's current price. View Analyst Price Targets for Indivior.

What is the consensus analysts' recommendation for Indivior?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Indivior.

Has Indivior been receiving favorable news coverage?

News coverage about INDV stock has trended negative this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Indivior earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave press coverage about the specialty pharmaceutical company a news buzz of 2.0 out of 10, meaning that recent news coverage is very unlikely to have an impact on the stock's share price in the near term.

Who are some of Indivior's key competitors?

Who are Indivior's key executives?

Indivior's management team includes the folowing people:
  • Mr. Shaun Thaxter, CEO & Exec. Director
  • Mr. Mark Crossley, CFO & Exec. Director
  • Dr. Christian Heidbreder, Chief Scientific Officer
  • Mr. Ingo Elfering, Chief Information & Innovation Officer
  • Mr. Jason Thompson, VP of Investor Relations

How do I buy shares of Indivior?

Shares of INDV and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 124.55.

What is Indivior's official website?

The official website for Indivior is http://indivior.com/.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.


MarketBeat Community Rating for Indivior (LON INDV)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  405 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  601
MarketBeat's community ratings are surveys of what our community members think about Indivior and other stocks. Vote "Outperform" if you believe INDV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe INDV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel